John C. Shryock

6.6k total citations
105 papers, 5.3k citations indexed

About

John C. Shryock is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, John C. Shryock has authored 105 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Cardiology and Cardiovascular Medicine, 72 papers in Molecular Biology and 29 papers in Physiology. Recurrent topics in John C. Shryock's work include Cardiac electrophysiology and arrhythmias (69 papers), Ion channel regulation and function (52 papers) and Adenosine and Purinergic Signaling (28 papers). John C. Shryock is often cited by papers focused on Cardiac electrophysiology and arrhythmias (69 papers), Ion channel regulation and function (52 papers) and Adenosine and Purinergic Signaling (28 papers). John C. Shryock collaborates with scholars based in United States, China and Italy. John C. Shryock's co-authors include Luiz Belardinelli, Yejia Song, Sridharan Rajamani, Lin Wu, Charles Antzelevitch, Miduturu Srinivas, Arvinder K. Dhalla, Lin Wu, Mark Ozeck and Daqing Wang and has published in prestigious journals such as Circulation, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

John C. Shryock

104 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. Shryock United States 41 3.1k 3.0k 1.3k 859 460 105 5.3k
Wilhelm Schmitz Germany 47 5.0k 1.6× 5.1k 1.7× 526 0.4× 970 1.1× 622 1.4× 249 8.0k
Hasso Scholz Germany 45 4.8k 1.5× 4.6k 1.5× 323 0.3× 1.5k 1.7× 629 1.4× 210 8.1k
Derek A. Terrar United Kingdom 35 2.2k 0.7× 2.6k 0.9× 579 0.5× 1.4k 1.6× 230 0.5× 111 3.8k
Shigetoshi Chiba Japan 24 1.6k 0.5× 1.5k 0.5× 263 0.2× 922 1.1× 226 0.5× 409 3.5k
Ulrich Quast Germany 34 927 0.3× 2.2k 0.8× 107 0.1× 905 1.1× 1.3k 2.8× 181 4.1k
C. van Breemen United States 39 1.3k 0.4× 3.0k 1.0× 266 0.2× 1.2k 1.4× 260 0.6× 74 4.8k
Bernward A. Schölkens Germany 45 4.1k 1.3× 2.3k 0.8× 347 0.3× 787 0.9× 1.2k 2.5× 125 7.8k
Norio Taira Japan 34 1.8k 0.6× 2.0k 0.7× 94 0.1× 969 1.1× 958 2.1× 250 4.3k
S. Jamal Mustafa United States 38 1.1k 0.3× 1.2k 0.4× 2.2k 1.8× 509 0.6× 514 1.1× 170 4.5k
Andrew A. Wolff United States 28 1.8k 0.6× 876 0.3× 121 0.1× 184 0.2× 261 0.6× 73 2.8k

Countries citing papers authored by John C. Shryock

Since Specialization
Citations

This map shows the geographic impact of John C. Shryock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Shryock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Shryock more than expected).

Fields of papers citing papers by John C. Shryock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Shryock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Shryock. The network helps show where John C. Shryock may publish in the future.

Co-authorship network of co-authors of John C. Shryock

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Shryock. A scholar is included among the top collaborators of John C. Shryock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Shryock. John C. Shryock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shryock, John C., Yejia Song, Sridharan Rajamani, Charles Antzelevitch, & Luiz Belardinelli. (2013). The arrhythmogenic consequences of increasing late INa in the cardiomyocyte. Cardiovascular Research. 99(4). 600–611. 101 indexed citations
3.
Viatchenko‐Karpinski, Serge, Dmytro Kornyeyev, Peidong Fan, et al.. (2013). Intracellular Na+ Overload of Cardiomyocytes Causes ROS Induced CaMKII Activation, Leading to RYR Dysfunction and Diastolic Ca2+ Mishandling. Biophysical Journal. 104(2). 441a–441a. 1 indexed citations
4.
Chan, Kim W., et al.. (2012). Contribution of Local Anesthetic Binding Site Residues F1760 and Y1767 to Block of the Cardiac Na+ Channel, hNaV1.5, by Ranolazine. Biophysical Journal. 102(3). 324a–324a. 2 indexed citations
6.
Zhao, Gong, Suhua Zhang, John C. Shryock, et al.. (2011). Selective action of metoprolol to attenuate regadenoson-induced tachycardia in conscious dogs. Journal of Nuclear Cardiology. 19(1). 109–117. 3 indexed citations
7.
Yao, Lina, Peidong Fan, María Pía Arolfo, et al.. (2010). Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis. Nature Medicine. 16(9). 1024–1028. 80 indexed citations
8.
Shryock, John C., et al.. (2010). OUABAIN INCREASES LATE SODIUM CURRENT BY A CA2+/CALMODULIN KINASE-MEDIATED MECHANISM. Journal of the American College of Cardiology. 55(10). A2.E17–A2.E17. 2 indexed citations
9.
Wu, Yuzhi, Yejia Song, Luiz Belardinelli, & John C. Shryock. (2009). The Late Na+ Current (INa) Inhibitor Ranolazine Attenuates Effects of Palmitoyl-L-Carnitine to Increase Late INa and Cause Ventricular Diastolic Dysfunction. Journal of Pharmacology and Experimental Therapeutics. 330(2). 550–557. 31 indexed citations
10.
Wu, Lin, Sridharan Rajamani, Hong Li, et al.. (2009). Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na+current in the heart. American Journal of Physiology-Heart and Circulatory Physiology. 297(3). H1048–H1057. 52 indexed citations
11.
Hale, Sharon L., John C. Shryock, Luiz Belardinelli, Michael Sweeney, & Robert A. Kloner. (2008). Late sodium current inhibition as a new cardioprotective approach. Journal of Molecular and Cellular Cardiology. 44(6). 954–967. 115 indexed citations
12.
Zhao, Gong, John C. Shryock, E. J. Messina, et al.. (2008). Regadenoson, a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging, Does Not Have a Direct Effect on the QT Interval in Conscious Dogs. Journal of Cardiovascular Pharmacology. 52(5). 467–473. 9 indexed citations
13.
Lieu, Hsiao D., John C. Shryock, Gregory O. von Mering, et al.. (2007). Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. Journal of Nuclear Cardiology. 14(4). 514–520. 93 indexed citations
14.
Dhalla, Arvinder K., et al.. (2007). Antilipolytic Activity of a Novel Partial A1 Adenosine Receptor Agonist Devoid of Cardiovascular Effects: Comparison with Nicotinic Acid. Journal of Pharmacology and Experimental Therapeutics. 321(1). 327–333. 42 indexed citations
15.
Wu, Lin, S. Rajamani, John C. Shryock, et al.. (2007). Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone. Cardiovascular Research. 77(3). 481–488. 63 indexed citations
16.
Belardinelli, Luiz, et al.. (2002). Tonic activity of the rat adipocyte A1‐adenosine receptor. British Journal of Pharmacology. 135(6). 1457–1466. 32 indexed citations
17.
Baraldi, Pier Giovanni, Abdel Naser Zaid, Ilaria Lampronti, et al.. (2000). Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor. Bioorganic & Medicinal Chemistry Letters. 10(17). 1953–1957. 68 indexed citations
18.
Grant, Maria B., Roy Tarnuzzer, Sergio Caballero, et al.. (1999). Adenosine Receptor Activation Induces Vascular Endothelial Growth Factor in Human Retinal Endothelial Cells. Circulation Research. 85(8). 699–706. 139 indexed citations
19.
Shryock, John C. & Luiz Belardinelli. (1997). Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology. The American Journal of Cardiology. 79(12). 2–10. 477 indexed citations
20.
Shryock, John C., et al.. (1992). Evaluation of N-0861, (+-)-N6-endonorbornan-2-yl-9-methyladenine, as an A1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1292–1299. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026